Publications by authors named "Jan Hartinger"

Claim this Profile
E
ESCP best practice: development of the national methodology for the provision of clinical-pharmaceutical care and its implementation in the healthcare system of the Czech Republic.
Jan Miroslav Hartinger, Ivana Tašková, Jana Gregorová, Ondřej Slanař, Daniela Fialová

Int J Clin Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: ESCP best practice: development of the national methodology for the provision of clinical-pharmaceutical care and its implementation in the healthcare system of the Czech Republic.
Jan Miroslav Hartinger, Ivana Tašková, Jana Gregorová, Ondřej Slanař, Daniela Fialová

Int J Clin Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin loading dose individualization in a population of obese patients undergoing haemodialysis based on population pharmacokinetic model.
Lucie Polášková, Jan Miroslav Hartinger, Irena Murínová, Pavel Michálek, Ondřej Slanař

J Chemother· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacotherapy of carbamazepine-treated patient after bariatric surgery: a complex interplay between altered absorption and drug-drug interactions.
Alena Pilková, Jan Hartinger, Ondřej Slanař, Martin Matoulek

Eur J Hosp Pharm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avacopan as an add-on therapy for ANCA-associated vasculitis: a pharmacological overview.
Vladimir Tesar, Jan Miroslav Hartinger, Zdenka Hruskova

Expert Rev Clin Pharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polypragmazie a jak jí předcházet.
Jan Miroslav Hartinger, Daniel Laurus Bobek

Cas Lek Cesk· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-based Dosing Individualization of Mycophenolate Mofetil in Solid Organ Transplanted Patients.
Sara Merdita, Pavel Ryšánek, Jan Miroslav Hartinger, Ondřej Slanař, Martin Šíma

Prague Med Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approach to adherence assessment based on parent drug and metabolite pharmacokinetics: pilot study with spironolactone.
Alena Pilkova, Martin Sima, Jan Miroslav Hartinger, Thi Minh Phuong Nikrynova Nguyen, Vera Maresova

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis.
Jan Miroslav Hartinger, Martin Šíma, Zdenka Hrušková, Alena Pilková, Vojtěch Krátký

Biomed Pharmacother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioavailability of Orally Administered Drugs After Bariatric Surgery.
Eliška Dvořáčková, Alena Pilková, Martin Matoulek, Ondřej Slanař, Jan Miroslav Hartinger

Curr Obes Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elimination and penetration of amikacin into urine in patients with decreased glomerular filtration rate.
Jan Miroslav Hartinger, Eliška Dvořáčková, Vojtěch Krátký, Zdenka Hrušková, Marek Mysliveček

Clin Kidney J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding options of supportive care in IgA nephropathy.
Dita Maixnerova, Jan Hartinger, Vladimir Tesar

Clin Kidney J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions.
Jan Miroslav Hartinger, Eliska Dvorackova, Marek Myslivecek, Zdenka Hruskova, Martin Satny

Bratisl Lek Listy· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications.
Jan Miroslav Hartinger, Danica Michaličková, Eliška Dvořáčková, Karolína Hronová, Elke H J Krekels

Pharmaceutics· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and blood pressure control in patients with primary aldosteronism.
Thi Minh Phuong Nikrýnová Nguyen, Branislav Štrauch, Ondřej Petrák, Zuzana Krátká, Robert Holaj, Jan Hartinger

Blood Press· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives.
Jan Miroslav Hartinger, Vojtech Kratky, Zdenka Hruskova, Ondrej Slanar, Vladimir Tesar

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients.
Jan Miroslav Hartinger, Pavel Ryšánek, Ondřej Slanař, Martin Šíma

J Clin Pharm Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing of Aminoglycosides in Chronic Kidney Disease and End-Stage Renal Disease Patients Treated with Intermittent Hemodialysis.
Barbora Agatha Halouzková, Jan Miroslav Hartinger, Vojtěch Krátký, Vladimír Tesař, Ondřej Slanař

Kidney Blood Press Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring.
Jan Miroslav Hartinger, Martin Šíma, Karolína Hronová, Barbora Agátha Halouzková, Barbora Szonowská

J Chemother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy.
Danica Michaličková, Jan Miroslav Hartinger, Zuzana Hladinová, Vladimíra Bednářová, Barbora Szonowská

Eur J Clin Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Population pharmacokinetics‑pharmacodynamics of fondaparinux in dialysis‑dependent chronic kidney disease patients undergoing chronic renal replacement therapy.
Danica Michaličková, Jan Miroslav Hartinger, Zuzana Hladinová, Vladimíra Bednářová, Barbora Szonowská

Eur J Clin Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial dosing of intermittent vancomycin in adults: estimation of dosing interval in relation to dose and renal function.
Martin Šíma, Jan Hartinger, Tomáš Grus, Ondřej Slanař

Eur J Hosp Pharm· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses.
Martin Šíma, Danica Michaličková, Pavel Ryšánek, Petra Cihlářová, Martin Kuchař, Jan Miroslav Hartinger

Pharmaceutics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifampin-Releasing Triple-Layer Cross-Linked Fresh Water Fish Collagen Sponges as Wound Dressings.
Jan Miroslav Hartinger, Peter Lukáč, Mikuláš Mlček, Michaela Popková, Tomáš Suchý

Biomed Res Int· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective use of fondaparinux in patient with unresponsiveness to nadroparin.
Jan Miroslav Hartinger, Alžběta Svobodová, Ivana Malíková, Robert Šachl, Ondřej Slanař

J Clin Pharm Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis